What is the Y-tunnus number of PharmaLex Finland Oy?

PharmaLex Finland Oy is registered with PRH / YTJ under Y-tunnus 1775083-6.

What is the revenue of PharmaLex Finland Oy?

PharmaLex Finland Oy reported revenue of EUR 10,1M in 2025.

How many employees does PharmaLex Finland Oy have?

PharmaLex Finland Oy employs 80 people as of the latest annual report.

Who is the CEO of PharmaLex Finland Oy?

Pauliina Krista Lajunen is Chief Executive Officer of PharmaLex Finland Oy, in role since 2023.

Who is the chairman of PharmaLex Finland Oy?

Thomas Stefan Dobmeyer chairs the board of PharmaLex Finland Oy, in role since 2022.

Where is PharmaLex Finland Oy headquartered?

PharmaLex Finland Oy's registered address is Pakkalankuja 7.

Riskpilot← Back to search

Sign inGet full access

PharmaLex Finland Oy

OYActive

Y-tunnus 1775083-6Pakkalankuja 7, 01510 VantaaAll other professional, scientific and technical activities n.e.c. · NACE 7499Est. 200280 employeeswww.pharmalex.com

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2021	2022	2023	2024	2025
Revenue	10 788	10 894	8 495	11 230	10 087
Staff expenses	−6 476	−6 508	−4 829	−6 867	−6 645
EBITDA	1 860	2 071	1 047	971	−290
Depreciation & amort.	−42	−56	−37	−38	−33
EBIT	1 818	2 014	1 010	933	−323
Net financials	276	182	−0	51	5
Profit before tax	495	2 196	1 010	984	−318
Tax	416	436	200	196	2
Net profit	78	1 760	810	788	−320

Balance sheet

EUR thousands

Item	2021	2022	2023	2024	2025
Total assets	4 352	4 169	3 497	3 784	6 772
Equity	192	1 151	1 562	1 750	680
Long-term debt	340	339	0	0	3 130
Short-term debt	3 820	2 678	1 936	2 034	2 963
Total debt	4 160	3 017	1 936	2 034	6 092

Financial ratios

5-year trend

EBITDA margin

-2.9%

This company

15.8%

Market median

-118% vs market

20212025

Equity ratio

10.0%

This company

38.2%

Market median

-74% vs market

20212025

Return on equity

-47.1%

This company

18.4%

Market median

-356% vs market

20212025

Net profit margin

-3.2%

This company

8.1%

Market median

-140% vs market

20212025

Asset turnover

1.49×

This company

1.12×

Market median

+33% vs market

20212025

Debt / equity

8.96×

This company

0.62×

Market median

-1345% vs market

20212025

Annual reports & filings

Annual report 2025
Filed via PRH / YTJ · Period 2024-10-01 – 2025-09-30
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-10-01 – 2024-09-30
View PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-09-30
View PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View PDF

PharmaLex Finland Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on PharmaLex Finland Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on PharmaLex Finland Oy